Medicare Enrolled

Dr. Rami Manochakian, MD

Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
4500 SAN PABLO RD S, Jacksonville, FL 32224
9049532000
In practice since 2008 (17 years)
NPI: 1619112034 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manochakian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manochakian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Manochakian

Dr. Rami Manochakian is a hematology & oncology in Jacksonville, FL, with 17 years in practice. Based on federal Medicare data, Dr. Manochakian performed 44,891 Medicare services across 1,698 unique beneficiaries.

Between the years covered by Open Payments, Dr. Manochakian received a total of $41,943 from 11 pharmaceutical and/or device companies across 60 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Manochakian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 17% volume in FL$ $41,943 industry payments

Medicare Practice Summary

Medicare Utilization ↗
44,891
Medicare services
Top 17% in FL for hematology & oncology
1,698
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,641 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Filgrastim injection (Nivestym) for white blood cells10,740$0$1
Iron infusion (Feraheme)7,650$0$2
Pembrolizumab injection (Keytruda)6,002$43$204
Daratumumab injection (Darzalex)5,040$35$188
Anti-nausea injection (fosaprepitant)4,200$0$1
Darbepoetin injection (Aranesp) for anemia3,945$2$11
Denosumab injection (Prolia/Xgeva)2,100$18$90
Dexamethasone injection (steroid)956$0$4
Anti-nausea injection (ondansetron/Zofran)812$0$5
Injection, bortezomib, 0.1 mg625$5$9
Injection of additional new drug or substance into vein262$12$216
Office visit, established patient, complex (40-54 min)250$131$604
Anti-nausea injection (Aloxi/palonosetron)200$1$9
Injection, fluorouracil, 500 mg183$2$26
Injection, leucovorin calcium, per 50 mg179$3$19
Administration of chemotherapy into vein, 1 hour or less159$95$869
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg156$93$459
Leuprolide acetate (for depot suspension), 7.5 mg124$128$490
Drug injection, under skin or into muscle115$11$102
Collection of blood sample from implanted device99$17$135
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg98$3$35
Injection, carboplatin, 50 mg96$2$29
New patient office visit, complex (60-74 min)92$170$891
Office visit, established patient (30-39 min)71$90$450
Infusion, normal saline solution , 1000 cc66$2$82
Infusion into a vein for hydration, each additional hour64$10$114
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle62$55$352
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle58$26$200
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less55$45$426
Injection, magnesium sulfate, per 500 mg52$1$20
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less49$22$233
Administration of chemotherapy into vein, each additional hour48$22$212
Administration of additional new drug or substance into vein, 1 hour or less42$50$446
Injection, diphenhydramine hcl, up to 50 mg41$1$38
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour38$16$154
Infusion, normal saline solution, sterile (500 ml = 1 unit)33$1$78
Infusion into a vein for hydration, 31-60 minutes28$24$345
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l21$127$993
Injection of drug or substance into vein19$27$600
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion17$15$143
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional15$18$96
Office visit, established patient (20-29 min)15$62$296
Administration of additional new drug or substance into vein using push technique14$43$370
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.9% high complexity
80.5% medium
1.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$41,943
Total received (2018-2024)
Avg $5,992/year across 7 years
Top 16% in FL for hematology & oncology
11
Companies
60
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$33,530 (79.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,190 (19.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$223 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,285
2023
$3,910
2022
$52
2021
$1,010
2020
$6,112
2019
$15,162
2018
$2,412

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$14,652
Novocure Inc.
$8,173
Takeda Pharmaceuticals U.S.A., Inc.
$5,169
E.R. Squibb & Sons, L.L.C.
$4,098
Daiichi Sankyo Inc.
$3,953
Janssen Scientific Affairs, LLC
$3,190
ABBVIE INC.
$2,538
Foundation Medicine, Inc.
$69
Amgen Inc.
$42
ARRAY BIOPHARMA INC
$32
Janssen Biotech, Inc.
$27
Top 3 companies account for 66.7% of total payments
Associated products mentioned in payments ›
ALUNBRIG · Enhertu · FOUNDATIONONE · IMFINZI · Oncology · Optune Lua (NovoTTF-200T) · RYBREVANT · TAGRISSO · XALKORI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $93 per 100 Medicare services performed
Looking for a hematology & oncology in Jacksonville?
Compare hematology & oncologys in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
104
Per 100K population
10.3
County median income
$68,447
Nearest hospital
MAYO CLINIC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Manochakian is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (consulting-driven, top 16%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Manochakian experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Manochakian performed 10,740 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Manochakian receive payments from pharmaceutical companies?
Yes. Dr. Manochakian received a total of $41,943 from 11 companies across 60 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manochakian's costs compare to other hematology & oncologys in Jacksonville?
Dr. Manochakian's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manochakian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →